The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Acetylation of PGK1 promotes liver cancer cell proliferation and tumorigenesis
Abstract
Phosphoglycerate kinase 1 (PGK1) is an important enzyme in the metabolic glycolysis pathway. In this study, we observed a significant overexpression of PGK1 in liver cancer tissues and a negative correlation between PGK1 expression and liver cancer patient survival. Furthermore, depletion of PGK1 dramatically reduced cancer cell proliferation and tumorigenesis, indicating an oncogenic role of PGK1 in liver cancer progression. Moreover, we identified acetylation at the K323 site of PGK1 as an important regulatory mechanism for promoting its enzymatic activity and cancer cell metabolism. And we further characterized P300/cyclic adenosine monophosphate response element binding protein–binding protein–associated factor (PCAF) and Sirtuin 7 as the enzymes regulating K323 acetylation from both directions in liver cancer cells. Conclusion: These findings demonstrate a novel regulation of PGK1 as well as its important role in liver cancer progression. (H epatology 2017;65:515‐528).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717 · cited 1×
“To dissect the mechanism that increases PGK1 expression in liver cancer cell lines, we depleted endogenous c-Myc and hypoxia inducible factor 1a (Hif1a), which have been regarded as major transcriptional factors driving the metabolic reprogramming of cancer cells,((16-19)) and examined the expression of PGK1 levels in…”
BackgroundHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Dang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390
The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., & Nakatani, Y. (1996) · Cell · doi:10.1016/s0092-8674(00)82001-2 · Cited by 2,952
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1779 · Cited by 2,200
Mitochondrial reactive oxygen species trigger hypoxia-induced transcription
Chandel, N. S., Maltepe, E., Goldwasser, E., Mathieu, C. E., Simon, M. C., & Schumacker, P. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11715 · Cited by 1,926
Regulation of cellular metabolism by protein lysine acetylation
Zhao, S., Xu, W., Jiang, W., Yu, W., Lin, Y., Zhang, T., Yao, J., Zhou, L., Zeng, Y., Li, H., et al. (2010) · Science · doi:10.1126/science.1179689 · Cited by 1,910
Self-citationAcetylation of Metabolic Enzymes Coordinates Carbon Source Utilization and Metabolic Flux
Wang, Q., Zhang, Y., Yang, C., Xiong, H., Lin, Y., Yao, J., Li, H., Xie, L., Zhao, W., Yao, Y., et al. (2010) · Science · doi:10.1126/science.1179687 · Cited by 1,008
Links between metabolism and cancer
Dang, C. V. (2012) · Genes & Development · doi:10.1101/gad.189365.112 · Cited by 998
Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes
Altenberg, B., & Greulich, K. O. (2004) · Genomics · doi:10.1016/j.ygeno.2004.08.010 · Cited by 659
Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription
Ford, E., Voit, R., Liszt, G., Magin, C., Grummt, I., & Guarente, L. (2006) · Genes & Development · doi:10.1101/gad.1399706 · Cited by 629
SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation
Barber, M. F., Michishita-Kioi, E., Xi, Y., Tasselli, L., Kioi, M., Moqtaderi, Z., Tennen, R. I., Paredes, S., Young, N. L., Chen, K., et al. (2012) · Nature · doi:10.1038/nature11043 · Cited by 620
Lv, L., Li, D., Zhao, D., Lin, R., Chu, Y., Zhang, H., Zha, Z., Liu, Y., Li, Z., Xu, Y., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.04.025 · Cited by 610
Li, X., Jiang, Y., Meisenhelder, J., Yang, W., Hawke, D. H., Zheng, Y., Xia, Y., Aldape, K., He, J., Hunter, T., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.02.009 · Cited by 508
The allosteric regulation of pyruvate kinase by fructose-1,6-bisphosphate
Jurica, M. S., Mesecar, A., Heath, P. J., Shi, W., Nowak, T., & Stoddard, B. L. (1998) · Structure · doi:10.1016/s0969-2126(98)00021-5 · Cited by 426
Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth
Lin, R., Tao, R., Gao, X., Li, T., Zhou, X., Guan, K.-L., Xiong, Y., & Lei, Q.-Y. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.07.002 · Cited by 384
Protein profiles associated with survival in lung adenocarcinoma
Chen, G., Gharib, T. G., Wang, H., Huang, C.-C., Kuick, R., Thomas, D. G., Shedden, K. A., Misek, D. E., Taylor, J. M. G., Giordano, T. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2233850100 · Cited by 277
Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase
Lay, A. J., Jiang, X.-M., Kisker, O., Flynn, E., Underwood, A., Condron, R., & Hogg, P. J. (2000) · Nature · doi:10.1038/35048596 · Cited by 267
PIRET, J., MOTTET, D., RAES, M., & MICHIELS, C. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04680.x · Cited by 257
Altered sirtuin expression is associated with node-positive breast cancer
Ashraf, N., Zino, S., MacIntyre, A., Kingsmore, D., Payne, A. P., George, W. D., & Shiels, P. G. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603384 · Cited by 248
Central Role of c-Myc during Malignant Conversion in Human Hepatocarcinogenesis
Kaposi-Novak, P., Libbrecht, L., Woo, H. G., Lee, Y.-H., Sears, N. C., Conner, E. A., Factor, V. M., Roskams, T., & Thorgeirsson, S. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3357 · Cited by 188
Ocampo, A., Liu, J., Schroeder, E. A., Shadel, G. S., & Barrientos, A. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.05.013 · Cited by 187
Metabolic consequences of oncogenic IDH mutations
Parker, S. J., & Metallo, C. M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.05.003 · Cited by 158
Terazosin activates Pgk1 and Hsp90 to promote stress resistance
Chen, X., Zhao, C., Li, X., Wang, T., Li, Y., Cao, C., Ding, Y., Dong, M., Finci, L., Wang, J.-H., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1657 · Cited by 156
Evaluation of Midkine as a Diagnostic Serum Biomarker in Hepatocellular Carcinoma
Zhu, W., Guo, J., Guo, L., Jia, H., Zhu, M., Zhang, J., Loffredo, C. A., Forgues, M., Huang, H., Xing, X.-J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3363 · Cited by 139
Self-citationInsulin and mTOR Pathway Regulate HDAC3-Mediated Deacetylation and Activation of PGK1
Wang, S., Jiang, B., Zhang, T., Liu, L., Wang, Y., Wang, Y., Chen, X., Lin, H., Zhou, L., Xia, Y., et al. (2015) · PLoS Biology · doi:10.1371/journal.pbio.1002243 · Cited by 128
Self-citationTargeting LKB1 signaling in cancer
Korsse, S. E., Peppelenbosch, M. P., & van Veelen, W. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.12.006 · Cited by 109
Phosphoglycerate kinase 1 as a promoter of metastasis in colon cancer
Ahmad, S. S., Glatzle, J., Bajaeifer, K., Bühler, S., Lehmann, T. G., Königsrainer, I., Vollmer, J.-P., Sipos, B., AHMAD, S. S., Northoff, H., et al. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1971 · Cited by 108
Glut1 expression in T1 and T2 stage colorectal carcinomas
Sakashita, M., Aoyama, N., Minami, R., Maekawa, S., Kuroda, K., Shirasaka, D., Ichihara, T., Kuroda, Y., Maeda, S., & Kasuga, M. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00371-3 · Cited by 107
FLNA and PGK1 are Two Potential Markers for Progression in Hepatocellular Carcinoma
Ai, J., Huang, H., Lv, X., Tang, Z., Chen, M., Chen, T., Duan, W., Sun, H., Li, Q., Tan, R., et al. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000327946 · Cited by 95
Self-citationTumor suppressor WWOX regulates glucose metabolism via HIF1α modulation
Abu‐Remaileh, M., & Aqeilan, R. I. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.95 · Cited by 91
The growing complexity of HIF-1α’s role in tumorigenesis: DNA repair and beyond
Rohwer, N., Zasada, C., Kempa, S., & Cramer, T. (2012) · Oncogene · doi:10.1038/onc.2012.510 · Cited by 80
de Nigris, F., Cerutti, J. M., Morelli, C., Califano, D., Chiariotti, L., Viglietto, G., Santelli, G., & Fusco, A. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600636 · Cited by 78
Fu, L., Jia, H., Dong, Q., Wu, J., Zhao, Y., Zhou, H.-J., Ren, N., Ye, Q.-H., & Qin, L. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-49 · Cited by 63
Self-citationTuberous sclerosis complex: linking cancer to metabolism
Mieulet, V., & Lamb, R. F. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.05.001 · Cited by 53
Biochemical pathways that regulate acetyltransferase and deacetylase activity in mammalian cells
Mellert, H. S., & McMahon, S. B. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.06.010 · Cited by 53
Tang, S., Ho, M., Cho, H.-J., Lin, Y., Sun, G., Chi, K., Wang, Y., Jhou, R., Yang, W., & Sun, K. (2008) · International Journal of Cancer · doi:10.1002/ijc.23888 · Cited by 46
Functional changes in murine mammary cancer cells elicited by CoCl2-induced hypoxia
Borenstein, X., Fiszman, G. L., Blidner, A. G., Vanzulli, S. I., & Jasnis, M. A. (2010) · Nitric Oxide · doi:10.1016/j.niox.2010.07.003 · Cited by 19
Cited by
LncRNA‐mediated posttranslational modifications and reprogramming of energy metabolism in cancer
Tan, Y., Lin, J., Li, T., Li, J., Xu, R., & Ju, H. (2021) · Cancer Communications · doi:10.1002/cac2.12108 · Cited by 700
Macrophage-Associated PGK1 Phosphorylation Promotes Aerobic Glycolysis and Tumorigenesis
Zhang, Y., Yu, G., Chu, H., Wang, X., Xiong, L., Cai, G., Liu, R., Gao, H., Tao, B., Li, W., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.06.023 · Cited by 348
O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth
Nie, H., Ju, H., Fan, J., Shi, X., Cheng, Y., Cang, X., Zheng, Z., Duan, X., & Yi, W. (2020) · Nature Communications · doi:10.1038/s41467-019-13601-8 · Cited by 346
Liao, M., Yao, D., Wu, L., Luo, C., Wang, Z., Zhang, J., & Liu, B. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.12.003 · Cited by 261
Targeting glucose metabolism enzymes in cancer treatment: current and emerging strategies
Zhang, Y., Li, Q., Huang, Z., Li, B., Nice, E. C., Huang, C., Wei, L., & Zou, B. (2022) · Cancers · doi:10.3390/cancers14194568 · Cited by 144
Metadata
- Authors
- Hu, H., Zhu, W., Qin, J., Chen, M., Gong, L., Li, L., Liu, X., Tao, Y., Yin, H., Zhou, H., Zhou, L., Ye, D., Ye, Q., & Gao, D.
- Venue
- Hepatology
- Published
- 2016-11-29
- Volume
- 65
- Issue
- 2
- Pages
- 515-528
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W2534608553
- Cited by
- 269
- References
- 42
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.